Qianjin Pharmaceuticals: Four products are proposed to be selected for the 12th national centralized procurement of pharmaceuticals.

Qianjin Pharmaceutical announced that the company and its subsidiary, Qianjin Xiangjiang Pharmaceutical, will participate in the 12th batch of national centralized drug procurement bidding on July 31, 2026, with four products intended for selection, including Dydrogesterone Tablets, Elagolix Tablets, Baricitinib Tablets, and Bensyl Gliclazide Tablets. The procurement period will be from the date of the selection results until December 31, 2029.